Reference
1. Desai M, ter Kuile FO, Nosten F,
Mcgready R, Asamoa K. Epidemiology and burden of malaria in pregnancy.
Lancet Infectious Diseases. 2007;7(2):93-104.
2. Duffy PE, Fried M. Malaria in the
Pregnant Woman; 2005; 295:169–200..
3. Walker PGT, ter Kuile FO, Garske T,
Menendez C, Ghani AC. Estimated risk of placental infection and low
birthweight attributable to Plasmodium falciparum malaria in Africa in
2010: a modelling study. Lancet Glob Health. 2014;2(8):e460-e7.
4.
The PREGACT Study Group. Four
Artemisinin-Based Treatments in African Pregnant Women with Malaria. N
Engl J Med. 2016;374(10):913-27.
5. White NJ, Olliaro PL. Strategies
for the prevention of antimalarial drug resistance: Rationale for
combination chemotherapy for malaria. Parasitol Today.
1996;12(10):399-401.
6. World Health Organization.
Guidelines for the treatment of malaria. World Health Organization.
2006;6(2):632-46.
7. Shulman CE, Dorman EK, Cutts F,
Kawuondo K, Marsh K. Intermittent sulphadoxine-pyrimethamine to prevent
severe anaemia secondary to malaria in pregnancy: a randomised
placebo-controlled trial. Lancet. 1999;353(9153):632-6.
8. Kayentao K, Garner P, van Eijk AM,
Naidoo I, Roper C, Mulokozi A, et al. Intermittent preventive therapy
for malaria during pregnancy using 2 vs 3 or more doses of
sulfadoxine-pyrimethamine and risk of low birth weight in Africa:
systematic review and meta-analysis. Jama. 2013 Feb 13;309(6):594-604.
9. Gutman J, Kalilani L, Taylor S,
Zhou Z, Wiegand RE, Thwai KL, et al. The A581G Mutation in the Gene
Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the
Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in
Malawian Pregnant Women. Journal of Infectious Diseases.
2015;211(12):1997-2005.
10. Iriemenam NC, Shah M, Gatei W,
Eijk AMV, Ayisi J, Kariuki S, et al. Temporal trends of
sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in
Plasmodium falciparum parasites from pregnant women in western Kenya.
Malaria Journal. 2012;11(1):134.
11. World Health Organization.
Guidelines for the treatment of malaria. Third edition April 2015. 2015
2015:316.
12. Kakuru A, Staedke S, Chandramohan
D, Kajubi R, Andra T, Adrama H, et al. Impact of intermittent preventive
treatment of malaria in pregnancy with monthly
dihydroartemisinin-piperaquine on the incidence of malaria during
infancy. American Journal of Tropical Medicine and Hygiene.
2018;99(4):663.
13. Desai M, Gutman J, L’Lanziva A,
Otieno K, Juma E, Kariuki S, et al. Intermittent screening and treatment
or intermittent preventive treatment with dihydroartemisinin-piperaquine
versus intermittent preventive treatment with sulfadoxine-pyrimethamine
for the control of malaria during pregnancy in western Kenya: An
open-label, three-group, randomised controlled superiority trial. The
Lancet. 2015;386(10012):2507-19.
14. Kakuru A, Jagannathan P, Muhindo
MK, Natureeba P, Awori P, Nakalembe M, et al.
Dihydroartemisinin-piperaquine for the prevention of malaria in
pregnancy. New England Journal of Medicine. 2016;374(10):928-39.
15. Myint HY, Ashley EA, Day NPJ,
Nosten F, White NJ. Efficacy and safety of
dihydroartemisinin-piperaquine. Trans R Soc Trop Med Hyg.
2007;101(9):858-66.
16. Li L, Tian J, Tian H, Moher D,
Liang F, Jiang T, et al. Network meta-analyses could be improved by
searching more sources and by involving a librarian. Journal of Clinical
Epidemiology. 2014;67(9):1001-7.
17. Higgins JP, Altman DG, Gotzsche
PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool
for assessing risk of bias in randomised trials. Bmj. 2011 Oct
18;343:d5928.
18. Ge L, Tian JH, Li YN, Pan JX, Li
G, Wei D, et al. Association between prospective registration and
overall reporting and methodological quality of systematic reviews: a
meta-epidemiological study. Journal of Clinical Epidemiology.
2018;93:S0895435617300458.
19. Norris SL, Meerpohl JJ, Akl EA,
Schünemann HJ, Gartlehner G, Chen Y, et al. The skills and experience of
GRADE methodologists can be assessed with a simple tool. Journal of
Clinical Epidemiology. 2016;79:S0895435616301937.
20. Higgins JPT, Thompson SG, Deeks
JJ, Altman DG. Measuring inconsistency in meta-analyses. Bmj.
2003;327(7414):557-60.
21. Dawid P, Roland Brian B, Lun L,
Barbara P, Michaela E. Systematic review found AMSTAR, but not
R(evised)-AMSTAR, to have good measurement properties. Journal of
Clinical Epidemiology. 2015;68(5):574-83.
22. Madanitsa M, Kalilani L, Mwapasa
V, van Eijk AM, Khairallah C, Ali D, et al. Scheduled Intermittent
Screening with Rapid Diagnostic Tests and Treatment with
Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy
with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An
Open-Label Randomized Controlled Trial. PLoS Medicine. 2016;13(9).
23. Jagannathan P, Kakuru A, Okiring
J, Muhindo MK, Natureeba P, Nakalembe M, et al.
Dihydroartemisinin-piperaquine for intermittent preventive treatment of
malaria during pregnancy and risk of malaria in early childhood: A
randomized controlled trial. PLoS Medicine. 2018;15(7).
24. Kajubi R, Ochieng T, Kakuru A,
Jagannathan P, Nakalembe M, Ruel T, et al. Monthly
sulfadoxine–pyrimethamine versus dihydroartemisinin–piperaquine for
intermittent preventive treatment of malaria in pregnancy: a
double-blind, randomised, controlled, superiority trial. The Lancet.
2019;393(10179):1428-39.
25. Lawn JE, Blencowe H, Oza S, You
D, Lee AC, Waiswa P, et al. Every Newborn: progress, priorities, and
potential beyond survival. Lancet. 2014 Jul 12;384(9938):189-205.
26. Sowunmi A, Akano K, Ayede AI,
Adewoye EO, Ntadom G, Fatunmbi B, et al. Early rising asexual
parasitaemia in Nigerian children following a first dose of
artemisinin-based combination treatments of falciparum malaria. BMC
infectious diseases. 2017 Jan 31;17(1):110.
27. Reyburn H. New WHO guidelines for
the treatment of malaria. BMJ. 2010;340(may28 1):c2637-c.
28. Tongo OO, Orimadegun AE,
Akinyinka OO. Utilisation of malaria preventive measures during
pregnancy and birth outcomes in Ibadan, Nigeria. Bmc Pregnancy &
Childbirth. 2011;11(1):60-.
29. Chico RM, Chaponda EB, Ariti C,
Chandramohan D. Sulfadoxine-Pyrimethamine Exhibits Dose-Response
Protection Against Adverse Birth Outcomes Related to Malaria and
Sexually Transmitted and Reproductive Tract Infections. Clinical
Infectious Diseases. 2017;64(8):1043-51.
30. Li XX, Zheng Y, Chen YL, Yang KH,
Zhang ZJ. The reporting characteristics and methodological quality of
Cochrane reviews about health policy research. Health Policy.
2015;119(4):503-10.
31. Guyatt HL, Snow RW. Impact of
malaria during pregnancy on low birth weight in sub-Saharan Africa.
Clinical microbiology reviews. 2004 Oct;17(4):760-9, table of contents.
32. Desai M, Gutman J, Taylor SM,
Wiegand RE, Khairallah C, Kayentao K, et al. Impact of
sulfadoxine-pyrimethamine resistance on effectiveness of intermittent
preventive therapy for malaria in pregnancy at clearing infections and
preventing low birth weight. Clinical Infectious Diseases An Official
Publication of the Infectious Diseases Society of America.
2015;62(3):civ881.
33. Schwarz N, Adegnika A, Lp, Gabor
J, Agnandji S, Newman R, Lell B, et al. Placental malaria increases
malaria risk in the first 30 months of life. Clinical Infectious
Diseases. 2008;47(8):1017-25.
34. Gutman J, Kovacs S, Dorsey G,
Stergachis A, Kuile FOT. Safety, tolerability, and efficacy of repeated
doses of dihydroartemisinin-piperaquine for prevention and treatment of
malaria: a systematic review and meta-analysis. Lancet Infectious
Diseases. 2017;17(2):184-93.
35. Tian J, Zhang J, Ge L, Yang K,
Song F. The methodological and reporting quality of systematic reviews
from China and the USA are similar. J Clin Epidemiol. 2017 May;85:50-8.
36. Shulman CE, Dorman EK, Talisuna
AO, Lowe BS, Nevill C, Snow RW, et al. A community randomized controlled
trial of insecticide-treated bednets for the prevention of malaria and
anaemia among primigravid women on the Kenyan coast. Tropical medicine
& international health : TM & IH. 1998 Mar;3(3):197-204.
37. Feng G, A. SJ, Ebbie C, E. MM, J.
RS, Georges S. Decreasing Burden of Malaria in Pregnancy in Malawian
Women and Its Relationship to Use of Intermittent Preventive Therapy or
Bed Nets. Plos One. 2010;5(8):e12012.
38. Gamble C, Ekwaru JP, ter Kuile
FO. Insecticide-treated nets for preventing malaria in pregnancy.
Cochrane Database of Systematic Reviews. 2006;2(2):CD003755.
39. Ter Kuile FO, Parise ME, Verhoeff
FH, Udhayakumar V, Newman RD, van Eijk AM, et al. The burden of
co-infection with human immunodeficiency virus type 1 and malaria in
pregnant women in sub-saharan Africa. American Journal of Tropical
Medicine & Hygiene. 2004;71(2 Suppl):41.
40. Olaleye A, Okusanya BO, Oduwole
O, Esu E, Meremikwu M. A systematic review and meta-analysis of
dihydroartemisinin-piperaquine versus sulphadoxine-pyrimethamine for
malaria prevention in pregnancy. International journal of gynaecology
and obstetrics: the official organ of the International Federation of
Gynaecology and Obstetrics. 2019 Jul;146(1):43-55.
41. Yao L, Sun R, Chen YL, Wang Q,
Wei D, Wang X, et al. The quality of evidence in Chinese meta-analyses
needs to be improved. Journal of Clinical Epidemiology. 2016;74:73-9.